Who Paid My Doc
Axumin
Drug Diagnostic Imaging
NDC 69932-001-30
General payments
$864,134
Research payments
$4,698,096
Through program year 2021, $864,134 in general payments and $4,698,096 in research payments were reported against Axumin (Diagnostic Imaging).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $212,512 | 4,686 |
| 2021 | Research | $2,748,322 | 310 |
| 2020 | General | $187,306 | 1,295 |
| 2020 | Research | $889,308 | 158 |
| 2019 | General | $464,315 | 3,528 |
| 2019 | Research | $1,060,467 | 158 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 56 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
9,509 general · 626 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.